gold has been researched along with cb-839 in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Apartsin, E; Gorji, A; Janiak, C; Kahlert, UD; Kaul, M; Meuth, SG; Nickel, AC; Poonaki, E; Rademacher, L; Shafiee Ardestani, M | 1 |
1 other study(ies) available for gold and cb-839
| Article | Year |
|---|---|
CD133-Functionalized Gold Nanoparticles as a Carrier Platform for Telaglenastat (CB-839) against Tumor Stem Cells.
Topics: AC133 Antigen; Benzeneacetamides; Brain Neoplasms; Enzyme Inhibitors; Gold; Humans; Metal Nanoparticles; Neoplastic Stem Cells; Thiadiazoles | 2022 |